Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 1, 2012, Pages 56-63

  Fink, James R ^a   Carr, Robert B ^a   Matsusue, Eiji ^a   Iyer, Ramesh S ^a   Rockhill, Jason K ^a   Haynor, David R ^a   Maravilla, Kenneth R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

3 Tesla MRI; diffusion MRI; malignant glioma; perfusion MRI; postradiation injury; proton MR spectroscopy

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN BLOOD VOLUME; BRAIN METABOLISM; BRAIN TUMOR; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLIOMA; HUMAN; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION INJURY; RECURRENT CANCER; TREATMENT OUTCOME;

ADULT; AGED; AREA UNDER CURVE; BRAIN NEOPLASMS; DIAGNOSTIC IMAGING; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PERFUSION; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 83755229589     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22801     Document Type: Article

References (30)

1. Perry A, Schmidt RE,. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 2006; 111: 197-212.
2. Hoffman WF, Levin VA, Wilson CB,. Evaluation of malignant glioma patients during the postirradiation period. J Neurosurg 1979; 50: 624-628. (Pubitemid 9178240)
3. Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000; 217: 377-384.
4. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010; 28: 1963-1972.
5. Brandsma D, van den Bent MJ,. Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol 2009; 22: 633-638.
6. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997; 87: 516-524. (Pubitemid 27430397)
7. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000; 21: 901-909. (Pubitemid 30262837)
8. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G,. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001; 22: 1316-1324. (Pubitemid 32734804)
9. Rabinov JD, Lee PL, Barker FG, et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 2002; 225: 871-879. (Pubitemid 35387129)
10. Rock JP, Hearshen D, Scarpace L, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002; 51: 912-919; discussion 919-920.
11. Hein PA, Eskey CJ, Dunn JF, Hug EB,. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004; 25: 201-209. (Pubitemid 38235296)
12. Plotkin M, Eisenacher J, Bruhn H, et al. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 2004; 70: 49-58. (Pubitemid 39193997)
13. Rock JP, Scarpace L, Hearshen D, et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 2004; 54: 1111-1117; discussion 1117-1119.
14. Hollingworth W, Medina LS, Lenkinski RE, et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 2006; 27: 1404-1411. (Pubitemid 44260118)
15. Zeng QS, Li CF, Liu H, Zhen JH, Feng DC,. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int J Radiat Oncol Biol Phys 2007; 68: 151-158. (Pubitemid 46589825)
16. Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH,. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 2007; 84: 63-69. (Pubitemid 47103445)
17. Barajas RF Jr, Chang JS, Segal MR, et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009; 253: 486-496.
18. Hu LS, Baxter LC, Smith KA, et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 2009; 30: 552-558.
19. Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, Zarudzki L,. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol 2010; 48: 81-92.
20. McGirt MJ, Bulsara KR, Cummings TJ, et al. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. J Neurosurg 2003; 98: 14-20. (Pubitemid 36050442)
21. Brandes AA, Tosoni A, Spagnolli F, et al. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol 2008; 10: 361-367.
22. Matsusue E, Fink JR, Rockhill JK, Ogawa T, Maravilla KR,. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology 2010; 52: 297-306.
23. Hu LS, Baxter LC, Pinnaduwage DS, et al. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol 2010; 31: 40-48.
24. Paulson ES, Schmainda KM,. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008; 249: 601-613.
25. Liu G, Sobering G, Duyn J, Moonen CT,. A functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO). Magn Reson Med 1993; 30: 764-768. (Pubitemid 23360815)
26. Manka C, Traber F, Gieseke J, Schild HH, Kuhl CK,. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. Radiology 2005; 234: 869-877. (Pubitemid 40250831)
27. van Gelderen P, Grandin C, Petrella JR, Moonen CT,. Rapid three-dimensional MR imaging method for tracking a bolus of contrast agent through the brain. Radiology 2000; 216: 603-608. (Pubitemid 30599889)
28. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002; 224: 797-803. (Pubitemid 34919816)
29. Young R, Babb J, Law M, Pollack E, Johnson G,. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging 2007; 26: 1053-1063. (Pubitemid 47548167)
30. Law M, Young R, Babb J, Pollack E, Johnson G,. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007; 28: 761-766. (Pubitemid 46608621)